effect doxazosin blood pressur renin-angiotensin-aldosteron urinari kallikrein doxazosin new quinazoline-deriv postsynapt alpha antagonist random double-blind placebo-control studi effect blood pressur BP heart rate metabol function renal hormon administr singl oral morn dose fashion patient women men year mild uncompl essenti hypertens antihypertens effect dose biweekli mg/day mean end titration-point dose mg mean standard error mean week treatment diastol BP level equal mm Hg week treatment final mean dose mg/day BP patient mean supin mm Hg increas heart rate first-dos phenomenon renin-aldosteron system electrolyt excret renal function metabol paramet unchang urinari kallikrein excret good toler patient studi dri nose result long-term monotherapi doxazosin effect safe antihypertens agent mild essenti hypertens urinari kallikrein excret 